[
    [
        {
            "time": "",
            "original_text": "泰格医药：关于非公开发行股份解除限售的提示性公告",
            "features": {
                "keywords": [
                    "泰格医药",
                    "非公开发行",
                    "解除限售"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药：关于非公开发行股份解除限售的提示性公告",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-02-11",
            "original_text": "[快讯]泰格医药3742万股限售股2月11日解禁",
            "features": {
                "keywords": [
                    "泰格医药",
                    "限售股",
                    "解禁"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "[快讯]泰格医药3742万股限售股2月11日解禁",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "4年投出60个生物医药项目，平均IRR 80%，这家资产管理公司亮出“底牌”",
            "features": {
                "keywords": [
                    "生物医药",
                    "投资",
                    "IRR",
                    "资产管理"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "资产管理"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "4年投出60个生物医药项目，平均IRR 80%，这家资产管理公司亮出“底牌”",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]